Dexcom is in talks to acquire device firm Insulet

The US-based company behind glucose-monitoring systems could become a giant on the diabetes device market following a rumored acquisition of Insulet, a maker of insulin pumps.
Photo: Jens Kalaene/AP/Ritzau Scanpix
Photo: Jens Kalaene/AP/Ritzau Scanpix
By Ed Hammond and Michelle F. Davis, bloomberg

Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in diabetes devices, according to people with knowledge of the matter. Insulet rose as much as 16% in after-market trading on the news.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading